Luminex FLEXMAP 3D Instrument with xPONENT 4. 3 Software or Equal

Closed Pre-Solicitation Posted

Not the latest version. See the latest solicitation from .

Solicitation number
FDA-SSN24-120539
Agency
Responses due
Set-aside
No set-aside

Opportunity facts

Place of performance
Jefferson, Arkansas 72079, United States

Notice details come from SAM.gov. Updated .

About this opportunity

The U.S. Food and Drug Administration (FDA), Office of Acquisitions and Grants Services (OAGS), is seeking sources capable of providing a Luminex FLEXMAP 3D Instrument with xPONENT 4.3 Software, or an equal product, for use in approved research protocols. This requirement falls under NAICS code 334516 - Analytical Laboratory Instrument Manufacturing, with a small business size standard of 1,000 employees. Interested parties are asked to submit capability statements addressing the minimum technical requirements, past performance, applicable contract vehicles, and pricing information by June 21, 2024. The government will use the responses to determine if a future requirement should be set aside for small business, competed openly, or procured through sole-source procedures.

This pre-solicitation notice does not indicate any set-aside designation. The government has not provided any information about potential incumbents or the anticipated award value or budget range. The requirement is for an unspecified quantity of the FLEXMAP 3D Instrument and associated software.

Notice text

Luminex FLEXMAP 3D Instrument with xPONENT 4.3 Software or Equal per the attached Sources Sought Notice FDA-SSN24-120539.

Files

File Type Posted
FDA-SSN24-120539.pdf PDF

Notice history

Notice Type Posted
Luminex FLEXMAP 3D Instrument with xPONENT 4. 3 Software or Equal Latest solicitation Solicitation
This notice Original Pre-Solicitation

On GovTribe

Work this opportunity

  • Track it in your pipeline
  • Find teaming partners
  • Similar opportunities
  • Ask GovTribe AI about this opportunity

GovTribe for Federal Contractors